CLINICAL_TRIALS
trial_result
· 2025-09-04
Clinical Trial Update: Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study [Phase 2, Phase 3]
Summary
Phase 2/3 pilot study evaluating safety and pharmacokinetics of dolutegravir in pregnant women with HIV and their neonates; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Liverpool | Conditions: HIV, Pregnancy | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-09-04